Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience

doi:10.5315/wjh.v6.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9010)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

753

WORD

406

HTML

5232

Tables (1-4)

263

Sum=6654

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1064

Download

1292

Sum=2356

Feb 6, 2017 (publication date) through Dec 18, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Hematol. Feb 6, 2017; 6(1): 1-10
Published online Feb 6, 2017. doi: 10.5315/wjh.v6.i1.1

Table 3 Patients characteristics

Patient	Sex	Age at ASCT (yr)	Disease phase at ASCT	Time from diagnosis to ASCT (mo)	Indication for ASCT	Donor sex
1	M	22	1^st AP	50	Resistance to imatinib and clonal evolution	M
2	F	51	2^nd CP	14	Previous myeloid blastic phase	M
3	M	25	2^nd CP	61	Previous lymphoid blastic phase	M
4	M	33	1^st CP	37	Resistance to imatinib and dasatinib	M
5	F	54	1^st AP	103	Resistance to imatinib, nilotinib and dasatinib 1^st accelerated phase	F
6	M	65	1^st CP	133	Resistance to imatinib and nilotinib	F
7	F	49	1^st CP	62	Resistance to imatinib	M
8	M	53	2^nd CP	63	Previous myeloid blastic phase	M
9	M	41	1^st CP	51	Resistance to imatinib	M
10	M	61	1^st CP	75	Resistance to imatinib, nilotinib and dasatinib	F

ASCT: Allogeneic stem cell transplantation; AP: Accelerated phase; CP: Chronic phase; M: Male; F: Female.

Citation: Soyer N, Uysal A, Tombuloglu M, Sahin F, Saydam G, Vural F. Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience. World J Hematol 2017; 6(1): 1-10
URL: https://www.wjgnet.com/2218-6204/full/v6/i1/1.htm
DOI: https://dx.doi.org/10.5315/wjh.v6.i1.1